One can hypothesise that each of these permissive haplotypes presents different myelin basic protein epitopes, or different autoantigens, in a sophisticated specialized way, but detailed functional studies from transgenic animal MS models would be required for proof. The gene discussed is MBP; the disease is myeloid sarcoma.